The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2.
about
The Endocannabinoid System in the Postimplantation Period: A Role during Decidualization and PlacentationCannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammationEndocannabinoids as Guardians of MetastasisEndocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathwaysAlternative targets within the endocannabinoid system for future treatment of gastrointestinal diseasesCannabinoids, endocannabinoids, and cancerAnandamide induces cell death through lipid rafts in hepatic stellate cells.Increasing antiproliferative properties of endocannabinoids in N1E-115 neuroblastoma cells through inhibition of their metabolism.Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites.Identification of prostamides, fatty acyl ethanolamines, and their biosynthetic precursors in rabbit cornea.The contribution of cyclooxygenase-2 to endocannabinoid metabolism and actionCannabinoids and cancer: pros and cons of an antitumour strategy.The role of COX-2 in intestinal inflammation and colorectal cancerThe cannabinoid receptor inverse agonist AM251 regulates the expression of the EGF receptor and its ligands via destabilization of oestrogen-related receptor α proteinIncreased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon.Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?Changes in the endocannabinoid system may give insight into new and effective treatments for cancer.Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies.Receptor-dependent and receptor-independent endocannabinoid signaling: a therapeutic target for regulation of cancer growth.Targeting cannabinoid receptors in gastrointestinal cancers for therapeutic uses: current status and future perspectives.Anandamide oxidative metabolism-induced endoplasmic reticulum stress and apoptosis.Endocannabinoids in the gastrointestinal tract.Anticancer effects of anandamide on head and neck squamous cell carcinoma cells via the production of receptor-independent reactive oxygen species.Arachidonoyl ethanolamide (AEA)-induced apoptosis is mediated by J-series prostaglandins and is enhanced by fatty acid amide hydrolase (FAAH) blockade.Suppression of invasive properties of colorectal carcinoma SW480 cells by 15-hydroxyprostaglandin dehydrogenase gene.Expression of the cannabinoid type I receptor and prognosis following surgery in colorectal cancer.Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms.Cytotoxic effect induced by combination of polyamines metabolites and endocannabinoid, anandamide, on human cancer cells: a new anticancer strategy.Effect of anandamide on erythrocyte survival.Anti-invasion Effects of Cannabinoids Agonist and Antagonist on Human Breast Cancer Stem Cells.
P2860
Q21284856-92896230-3B63-430B-9872-6F5FC545D057Q24643922-2B52C9E7-208D-4C5F-B4E0-F368390F73DAQ26766163-43EBB0C5-2389-45CF-AC58-F6BD03E66355Q26823256-64E06471-45B2-49FE-9998-B8885487AC76Q26824588-654E8887-3633-4F00-ABB2-274905CF5CE9Q27694715-E9C07E3E-85CC-4E06-92D1-0044AAE874B6Q33522772-30557885-C46D-45FC-BBBD-1FD23F08B2BFQ34064728-1D06FAD9-57BF-4376-8BD5-49E32FEB79F9Q34471868-14EB48F1-5C53-4571-BC8C-062DD855D845Q34478780-8F15CF05-9D2F-4F6C-B694-336497787DA8Q34647348-B32133E8-D823-4AA2-B91D-B53575AA4A70Q35100892-BC57E20B-5A38-40AC-913B-1BDA99F7F483Q35234704-A26D606A-4970-4E9F-B1E0-E7DB9704200FQ35376123-8BD92BE8-9138-4370-9FD1-6B2D9A61B563Q37371891-9A6C0761-BD06-46FB-A9B6-127ABF3DCA36Q37546194-E141E6EB-8F1B-405E-970C-4A448A76A521Q37568679-A049C8E2-F06B-4D7D-ABB0-DD118964D549Q37960078-F5584AA4-8C0B-42F7-A68D-C03CCC27B78FQ38052298-F13A8FB4-C57F-41DE-A779-CAE1F7E624B5Q38640858-6CDC7853-0A0E-41B9-9B1B-3A8134A01BA8Q38715570-B5A2759E-361E-4289-A0ED-0423F335974BQ38931168-42FC6DB2-E3DF-41D4-9BBF-45C591E408D3Q38998420-0057B868-91CB-427A-929A-6132A705969EQ39571527-3AD1E40E-DF96-4561-A7D8-C685CE949A73Q39912197-30AF1A53-81DE-4339-B018-6DCE92A56497Q41763884-91E70224-583D-487E-9B75-2949ACA54CF5Q42700473-E9CA1941-3034-4F47-AE3A-C72FDB706EA1Q46219301-103D6814-8516-4F28-BA96-03A23078EBF6Q46920562-C9491F39-0EA7-448F-93C5-0875964F2A65Q55020492-E1659135-2B15-4E06-BA49-68C68A79C10B
P2860
The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The endogenous cannabinoid, an ...... ble role for cyclooxygenase 2.
@en
type
label
The endogenous cannabinoid, an ...... ble role for cyclooxygenase 2.
@en
prefLabel
The endogenous cannabinoid, an ...... ble role for cyclooxygenase 2.
@en
P2093
P2860
P50
P921
P356
P1433
P1476
The endogenous cannabinoid, an ...... ible role for cyclooxygenase 2
@en
P2093
C Paraskeva
H A Patsos
R R H Dobson
P2860
P304
P356
10.1136/GUT.2005.073403
P407
P577
2005-08-11T00:00:00Z